M
Mirati Therapeutics
Biotechnology company located in 9363 towne centre dr, san diego, ca, united states
About Mirati Therapeutics
Mirati Therapeutics is a biotechnology company that operates in the healthcare sector, specifically in the oncology market. The company focuses on developing novel therapeutics for the treatment of cancer. Mirati's primary area of research and development is on RAS proteins, which are often mutated in many types of cancer, including non-small cell lung cancer and pancreatic cancer.
The company's business model revolves around the development of these innovative cancer treatments. Once these treatments have been developed and approved, they are sold to healthcare providers who administer them to patients. The company's revenue is generated from the sales of these treatments.
Mirati's key product in development is a KRAS inhibitor, which is designed to target and inhibit the function of the KRAS protein, a common mutation in many types of cancer. This could potentially provide a new treatment option for patients with these types of cancer, for whom there are currently limited treatment options.
In addition to its KRAS inhibitor, Mirati is also developing a combination therapy of sitravatinib and nivolumab for the treatment of non-small cell lung cancer. This combination therapy is currently in Phase III clinical trials.
In summary, Mirati Therapeutics is a biotech company that operates in the oncology market, developing innovative treatments for cancer. The company generates revenue from the sales of these treatments to healthcare providers.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Listing
- IPO 2013
- Outcome tier
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
News
Open roles
Mirati Therapeutics in the San Diego ecosystem
The Mirati Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
99 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Mirati Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Mirati Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


